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ABSTRACT
Introduction: Intellectual disability affects 2% – 3% of the general population, with a chromosomal abnormality being found in 4% – 28% 
of these patients and a cryptic subtelomeric abnormality in 3% – 16%. In most cases, these subtelomeric rearrangements are submicro-
scopic, requiring techniques other than conventional karyotype for detection. They may be de novo or inherited from an affected parent 
or from a healthy carrier of a balanced chromosomal abnormality. The aim of this study was to characterize patients from our medical 
genetics center, in whom both a deletion and duplication in subtelomeric regions were found.
Material and Methods: Clinical and cytogenetic characterization of 21 probands followed at our center, from 1998 until 2017, with 
subtelomeric rearrangements.
Results: There were 21 probands from 19 families presenting with intellectual disability and facial dysmorphisms. Seven had behavior 
changes, five had epilepsy and 14 presented with some other sign or symptom. Four had chromosomal abnormalities detected by 
conventional karyotype and four were diagnosed by array-comparative genomic hybridization. In four cases, parental studies were not 
possible. The online mendelian inheritance in man classification was provided whenever any of the phenotypes (deletion or duplication 
syndrome) was dominant.
Discussion: Patients and relevant family members were clinically and cytogenetically characterized. Although rare, subtelomeric 
changes are a substantial cause of syndromic intellectual disability with important familial repercussions. It is essential to remember 
that a normal array-comparative genomic hybridization result does not exclude a balanced rearrangement in the parents.
Conclusion: Parental genetic studies are essential not only for a complete characterization of the rearrangement, but also for accurate 
genetic counselling and screening of family members at risk for recurrence.
Keywords: Intellectual Disability/genetics; Subtelomeric Rearrangements Gene Rearrangement/genetics; Telomere/genetics
RESUMO
Introdução: O défice intelectual afeta 2% – 3% da população geral, sendo encontrada uma alteração cromossómica em 4% – 28% 
dos casos e uma alteração subtelomérica em 3% – 16%. Estas alterações subteloméricas são, na maioria dos casos, submicroscópi-
cas, não sendo detetadas no cariótipo convencional. Podem ser de novo ou herdadas de um progenitor afetado ou de um progenitor 
saudável portador de um rearranjo equilibrado. O objetivo deste estudo foi caracterizar os doentes seguidos no nosso centro de gené-
tica médica com uma deleção e uma duplicação nas regiões subteloméricas. 
Material e Métodos: Caracterização clínica e citogenética de 21 probandos com alterações subteloméricas seguidos no nosso centro 
entre 1998 e 2017.
Resultados: Foram caracterizados 21 probandos que apresentavam défice intelectual e dismorfia facial, pertencentes a 19 famílias. 
Sete tinham alterações do comportamento, cinco epilepsia e 14 outro sinal ou sintoma. Quatro tinham alterações no cariótipo e quatro 
foram diagnosticados por array-comparative genomic hybridization. Em quatro famílias não foi possível o estudo dos progenitores. 
Quando um dos fenótipos era dominante (síndrome de deleção ou duplicação), foi atribuída a classificação online mendelian inheri-
tance in man.
Discussão: Foi realizada classificação dos doentes e das famílias. As alterações nas regiões subteloméricas são, apesar de raras, 
uma causa substancial para défice intelectual sindrómico com repercussões familiares importantes. É essencial lembrar que um array-
comparative genomic hybridization normal não exclui um rearranjo equilibrado familiar.
Conclusão: O estudo dos progenitores é essencial não só para caracterização completa do rearranjo mas também para um aconse-
lhamento genético preciso e identificação de familiares em risco de recorrência.
Palavras-chave: Deficiência Intelectual/genética; Rearranjo Génico/genética; Telómero/genética
INTRODUCTION
Intellectual disability, previously known as mental retar-
dation, affects 2% – 3% of the general population.1–3 The 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-5 defines intellectual disability as a disorder with 
onset during the developmental period that includes both 
intellectual and adaptive functioning deficits in conceptual, 
social and practical domains. It can be classified into mild, 
moderate, severe and profound intellectual disability, accord-
ing to its severity.4,5 The aetiology of ID is heterogeneous 
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and includes both genetic and environmental causes,2 and 
sometimes it is multifactorial. Most patients, particularly 
those with moderate/severe ID and with dysmorphic fea-
tures/congenital abnormalities, have a genetic aetiology, 
which can be a chromosomal imbalance or a single gene 
pathogenic variant. A chromosomal abnormality is found 
in 4% – 28% of patients with ID.2,5 Subtelomeric regions 
are gene-rich chromosomal regions with a highly repetitive 
structure, frequently involved in chromosomal rearrange-
ments.6,7 Cryptic subtelomeric abnormalities, syndromic or 
isolated, are well known causes of ID, and are responsible 
for 3% – 16% of diagnoses. 
These subtelomeric rearrangements are predominant-
ly submicroscopic [i.e. smaller than 5 megabases (Mb)], 
requiring techniques other than conventional karyotype for 
detection. Karyotype with fluorescent in situ hybridization 
(FISH) was the first diagnostic approach for these subtel-
omeric abnormalities. Multiplex ligation-dependent probe 
amplification (MLPA), a semi-quantitative methodology, 
allowed a better characterization of duplications or dele-
tions. Currently, array-comparative genomic hybridization 
(aCGH) is used as the first tier-test for these patients.8,9 All 
the above techniques have been used as routine tests for 
identifying these patients.2,3,8,10 
An accurate family history may show important clues for 
a possible inherited rearrangement, mainly more than one 
family member affected or history of recurrent pregnancy 
losses. In fact, these subtelomeric abnormalities may be de 
novo or inherited. An unbalanced rearrangement may be 
inherited from an affected parent or from a healthy carrier 
of a balanced chromosomal abnormality. Parental genetic 
studies are thus essential not only for a complete character-
ization of the rearrangement (de novo or inherited) but also, 
and more importantly, for accurate genetic counselling and 
screening of family members at risk for recurrence. 
Following the identification of a patient (case 1) in whom 
aCGH showed the presence of a deletion and a duplication 
in subtelomeric regions, and complementary studies in par-
ents confirmed that the mother was a carrier of a balanced 
subtelomeric cryptic translocation, we decided to review 
and characterize the patients from our medical genetics 
center, from clinical and cytogenetic perspectives, in whom 
both deletion and duplication on subtelomeric regions 
were found. With this work, our main objective was to raise 
awareness for these rare genetic syndromes as well as to 
the importance of familial studies. 
MATERIAL AND METHODS
Our study included 21 probands followed at our medical 
genetics center, from 1998 until 2017, who have simultane-
ously a deletion and a duplication in chromosomal subtel-
omeric regions. We describe gender, age at first consulta-
tion, somatometry, craniofacial and other dysmorphisms or 
congenital abnormalities, family history, as well as cytoge-
netic findings in patients and parents.
Written informed consent was obtained for all published 
photos. 
RESULTS
Results are summarized in Table 1, Table 2 and Figs. 1 
to 3. Twenty one probands (eight males and 13 females) 
from 19 families presented with developmental delay/intel-
lectual disability (11 cases with severe, four with moderate 
and six with mild ID) and facial dysmorphisms (Table 1A 
and Fig. 4). Seven had behaviour changes, five had epi-
lepsy and 14 presented with some other sign or symptom. 
Cases 4 to 6 represent a brother, a sister and a mater-
nal cousin from the same family. Four cases presented 
with visible G-bands by trypsin using Leishman (GTL) 
banding chromosomal abnormalities: three of them with 
subtelomeric abnormalities [case 18: 46,XY,der(6)t(6;9)
(q27;p12); case 19:  46,XX,der(8)t(4;8)(p16,1;p23,1); case 
21: 46,XX,der(3)t(3;11)(p26.2;p15.4)pat], and case 15 had 
a balanced and non-pathogenic robertsonian translocation 
[45,XX,rob(13;14)(q10;q10)], in addition to the subtelomeric 
submicroscopic abnormalities. Four cases were diagnosed 
by aCGH and the others by MLPA/FISH. In four cases, the 
parental clinical and cytogenetic studies were not possi-
ble. Of the cases in which family studies were possible, six 
were de novo events, seven were inherited from a balanced 
cryptic rearrangement and three probands inherited the 
abnormality from a similarly affected parent. In case 21 the 
translocation was shown to have been inherited from the 
paternal grandfather. Most cases presented with phenotypic 
characteristics of both deletion and duplication syndromes 
involved in the rearrangement. Therefore, the OMIM classi-
fication was provided whenever any of the phenotypes was 
dominant (Tables 1A and 1B). 
DISCUSSION
Subtelomeric regions are gene-rich chromosomal 
regions responsible for a significant number of patients with 
syndromic ID. At Centro Hospitalar Universitário do Porto, 
21 cases with a subtelomeric chromosomal rearrangement 
have been diagnosed and characterized, and accurate 
genetic counselling was offered. 
Case 1 presented with a phenotype more compatible 
with chromosome 16p13.3 duplication syndrome. This 
19%
29%
52%
mild moderate severe
Figure 1 – Intellectual disability
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Table 1A – Clinical and cytogenetic characterization of our patients’ cohort 
Case Age* Sex Facial Dysmorphisms DD/ID Behaviour changes Epilepsy Other
1 13m F High forehead, small, upslanting palpebral fissures, 
flat philtrum, small mouth with thin lips
mild – – Hypotonia
2 25y F Frontal bossing, hypertelorism, long nose with overhanging nasal tip severe – + –
3 29y M Round face, synophrys,  large, smooth philtrum severe + + Short stature
4 12m M
Mild plagiocephaly and facial asymmetry, flat midface, 
straight eyebrows, deeply set eyes with downslanting 
palpebral fissures, small nose with flat nasal bridge 
and bulbous tip, downturned corners of mouth
severe + + –
5 11m F
Mild plagiocephaly and facial asymmetry, flat midface, 
straight eyebrows, deeply set eyes with downslanting 
palpebral fissures, small nose with flat nasal bridge 
and bulbous tip, downturned corners of mouth
severe + + –
6 7m F
Mild plagiocephaly and facial asymmetry, flat midface, 
straight eyebrows, deeply set eyes with downslanting 
palpebral fissures, small nose with flat nasal bridge 
and bulbous tip, downturned corners of mouth
severe + + –
7 3y F Frontal bossing, arched eyebrows, flat nasal bridge, small low-set dysplastic ears severe – –
Obesity, type 4 
brachydactyly, 
hypotonia
8 10y F Frontal bossing, arched eyebrows, flat nasal bridge, small low-set dysplastic ears severe + –
Short stature, type 4 
brachydactyly
9 39y F Downslanting palpebral fissures, arched eyebrows, thick lips severe – – Overweight
10 12y F Small eyes, long nose, large teeth severe + – Severe scoliosis
11 22m M High forehead, small low-set ears, thick eyebrows, small nose, micrognathia severe – –
Cleft palate, 
hypotonia, ataxia
12 3y M
Macrocephaly with frontal bossing, low-set ears, 
telecanthus, hyperthelorism, decentered elliptical 
pupils
mild – – MVP, Rieger’s anomaly
13 39y F
Rough face, blepharophimosis, telecanthus, long 
nose with overhanging nasal tip, prognathism, large, 
protruding tongue
severe – – Scoliosis
14 8y M Microcephaly, small forehead, prominent nose with hypoplastic nares, microretrognathia moderate – – –
15 11y F Microcephaly, bitemporal narrowing, pointed nose, microretrognathia, mentonian groove moderate + – Failure to thrive
16 23y M
Small forehead, dysplastic ears, arched eyebrows, 
epicanthus, telecanthus, large mouth with microdontia 
and some conical teeth, micrognathia
mild – – –
17 4y F Blepharophimosis, left ptosis, epicanthus, strabismus mild – – –
18 3m M
High forehead, simple cup-shaped ears, epicanthus, 
small palpebral fissures, broad nose with bulbous tip, 
microretrognathia
moderate – –
Failure to thrive, 
kyphoscoliosis, 
short 5th finger with 
clinodactily, hypotonia
19 3y F Broad forehead, midface hypoplasia, big cheeks, spoon ear, depressed nasal bridge, strabismus mild – –
Foetal growth 
restriction, speech 
delay
20 11m M
Brachycephaly, round face, epicanthus, upslanting 
palpebral fissures, bulbous nose with anteverted 
nares, thin lips, low-set ears
mild – –
Short puffy hands 
and feet, right 
cryptorchidism, 
hypotonia, mongolian 
spot
21 1m F
High front, small, low-set and posteriorly rotated 
ears, downslanting palpebral fissures, bulbous nose 
tip with wide anteverted nares, large mouth with 
macroglossia, mild micrognathia
moderate – –
Loose skin, umbilical 
hernia, strabismus, 
scoliosis
*age at first consultation; **OMIM dominant phenotoype when it was possible to characterize; y: years-old; m: months-old; M/F: male/
female; DD/ID: developmental delay/intellectual disability; mat/pat: maternal/paternal; dn: de novo; unk: unknown; del/dup: deletion/dupli-
cation; (un)bal: (un)balanced; Sdr: syndrome.
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Table 1B – Prevalence of children from 0 to 9 years old exposed to SHS at home according to parents’ tobacco consumption, by region 
Case Karyotype Chromosomal abnormalities
Genetic 
Study Type Dominant phenotype**
1 46,XX del2q37.3,dup16p13.3 aCGH
mat 
translocation bal
#613458 Chromosome 
16p13.3 Duplication Sdr
2 46,XX del22q13.33,dup19q13.4
MLPA, 
FISH
mat 
translocation bal
#606232 Phelan-
McDermid Sdr
3 46,XY del5p15.33,dup18p11.32
MLPA, 
FISH
mat 
translocation unbal
#123450 Chromosome 5p 
Deletion Sdr
4 46,XY del1p36.33,dup14q32.3
MLPA, 
FISH
mat 
translocation bal
#607872 Chromosome 
1p36 Deletion Sdr
5 46,XX del1p36.33,dup14q32.3
MLPA, 
FISH
mat 
translocation bal
#607872 Chromosome 
1p36 Deletion Sdr
6 46,XX del1p36.33,dup14q32.3
MLPA, 
FISH
pat 
translocation bal
#607872 Chromosome 
1p36 Deletion Sdr
7 46,XX del2q37.3,dup12q24.33
MLPA, 
FISH unk unk
#600430 Chromosome 
2q37 Deletion Sdr
8 46,XX del2q37.3,dup17q25.3
MLPA, 
FISH
mat 
translocation bal
#600430 Chromosome 
2q37 Deletion Sdr
9 46,XX del12p13.33,dup12q24.33
MLPA, 
FISH pat inversion bal
10 46,XX del8p23.3,dup4p16.3
MLPA, 
FISH dn dn
11 46,XY del6p25.3,dup17q25.3 FISH dn dn
#612582 Chromosome 
6pter-p24 Deletion Sdr
12 46,XY del6p25.3,dupXq28/Yq12
MLPA, 
FISH
pat 
translocation unbal
#612582 Chromosome 
6pter-p24 Deletion Sdr
13 46,XX del18p11.21,dup11p15.5
MLPA, 
FISH unk unk
14 46,XY del6q27,dup22q13.33
MLPA, 
FISH unk unk
#615538 Chromosome 
22q13 Duplication Sdr
15 45,XX,rob(13;14)(q10;q10) del15q26.3,dup19p13.3 aCGH
mat deletion,
pat duplication unbal
#612626 Chromosome 
15q26-qter Deletion  Sdr
16 46,XY del4q35.2,dup1p36.33
MLPA, 
FISH unk unk
17 46,XX del14q32.33,dup20q13.33
MLPA, 
FISH dn dn
18 46,XY,der(6)t(6;9)(q27;p12) del6q27,dup9p12
Karyotype, 
FISH dn dn
19 46,XX,der(8)(4;8)(p16,1;p23,1) del8p23.3p23.1,dup4p16.3p16.1
aCGH, 
Karyotype dn dn
20 46,XY del18q22.3q23,dup21q22.2q22.3 aCGH dn dn #190685 Down Sdr
21 46,XX,der(3)t(3;11)(p26.2;p15.4)pat del3p26.2, dup11p15.4
Karyotype, 
MLPA
pat 
translocation
bal and 
pat 
inherited
#130650 Beckwith-
Wiedemann Sdr
*age at first consultation; **OMIM dominant phenotoype when it was possible to characterize; y: years-old; m: months-old; M/F: male/
female; DD/ID: developmental delay/intellectual disability; mat/pat: maternal/paternal; dn: de novo; unk: unknown; del/dup: deletion/dupli-
cation; (un)bal: (un)balanced; Sdr: syndrome.
syndrome is characterized by ID, facial dysmorphisms 
(high forehead, sparse eyebrows, blepharophimosis with 
palpebral ptosis, short nose, everted upper lip, high-arched 
palate and cupped ears), pre and postnatal growth defi-
ciency, clef palate, congenital heart defects and urogenital 
abnormalities.11
Case 2 presented mainly with a phenotype consistent 
with Phelan-McDermid syndrome, characterized by neo-
natal hypotonia, global developmental delay, moderate to 
severe ID, absent or severely impaired speech, normal to 
accelerated growth, large fleshy hands, dysplastic toenails, 
decreased sudoresis with tendency to overheat and behav-
iour changes (chewing, decreased perception of pain, autis-
tic-like features).12  
Case 14 presented with chromosome 22q13 duplication 
syndrome, the duplication occurring in the same chromo-
somal region where there was a deletion in case 2; this 
syndrome was described in patients presenting with global 
developmental delay, prenatal and postnatal growth retar-
dation, hypotonia, facial dysmorphisms (microcephaly, 
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Figura 3 – Cytogenetic characteristics
Figure 2 – Clinical characteristics
micrognathia, hypertelorism and low-set ears), cleft lip and 
palate, congenital heart disease, kidney, genital and skel-
etal abnormalities. However, different sized duplications 
have shown variable phenotypic severity and inconsistent 
phenotype even in affected members of the same family.13 
Case 3 presented with severe developmental delay, 
behaviour changes, epilepsy, short stature and facial dys-
morphisms (round face, micrognathia, epicanthic folds, 
hypertelorism). This phenotype is mainly caused by the 
5p15.33 deletion, compatible with chromosome 5p deletion 
syndrome.14   
Cases 4, 5 and 6 are three affected individuals (a boy 
and two girls) within the same family. They all presented 
with a phenotype characteristic of chromosome 1p36 dele-
tion syndrome: this is a well known syndrome comprising 
a characteristic facial appearance (microcephaly, brachy-
cephaly, prominent forehead, midface hypoplasia, deep-set 
eyes with straight eyebrows, thick ear helices, flat nose and 
nasal bridge and pointed chin), hypotonia, developmental 
delay, growth retardation, seizures, hearing impairment, 
visual problems, cardiovascular and limb abnormalities.15,16 
Both cases 7 and 8 presented with some phenotypic 
features of chromosome 2q37 deletion syndrome, which is 
characterized by facial dysmorphisms (prominent forehead, 
round face, midface hypoplasia, sparse arched eyebrows, 
deep-set eyes, depressed nasal bridge, thin upper lip and 
dysmorphic ears), short stature, obesity, brachydacty-
ly type E, mild to moderate ID and behavioural problems. 
Other major malformations may occur, including congenital 
heart disease, central nervous system malformations, and 
gastrointestinal or genitourinary abnormalities.17,18 
Vaglio et al have described a case of a boy present-
ing with partial monosomy 12p and trisomy 12q and com-
pared him with other cases described in the literature. 
As in our case 9, patients with this chromosomal abnor-
mality show clinical features that are characteristic of both 
deletion and duplication syndromes. It was not possible to 
detect predominance of either. All of these cases occurred 
as a consequence of a balanced inversion present in a 
healthy parent.19 
The chromosomal study of cases 10 and 19 revealed in 
both cases a deletion in 8p23.3 and a duplication in 4p16.3. 
Epilepsy OtherFacial
dymorphisms
Behaviour
alteration
0
5
10
15
20
21
7
5
14
25
7 8 96543210
unknown
inherited unbalanced translocation
inherited balanced translocation
de novo
Table 2 – Demographic data 
< 2y 2 – 18y > 18y
M 4 2 2
F 4 6 3
Total 8 8 5
Y: years-old; m: months-old; M/F: male/female
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In fact, the translocation between the subtelomeric regions 
of chromosomes 4 and 8 is considered the second most 
common in humans. The 8p23 duplication has been asso-
ciated with ID, autism and psychiatric manifestations, as 
well as dysmorphisms (such as high forehead, epicanthic 
folds, hypertelorism, small eyes, strabismus, long philtrum, 
micrognathia, low-set malformed ears) and cardiac or renal 
malformations. The 4p16.3 duplication causes mild devel-
opmental delay/ID, speech delay, growth delay and mild 
dysmorphic features (hypertelorism, epicanthic folds and 
abnormal ears). Both cases have phenotypic manifesta-
tions that are very different, and it is hard to categorize their 
characteristics into a specific syndrome. Patient 19 seems 
to fit better into 4p16.3 duplication characteristics.20–22 
Both cases 11 and 12 presented with chromosome 
6pter-p24 deletion syndrome, characterized by ID, oph-
thalmologic abnormalities, craniofacial dysmorphisms 
(macrocephaly, prominent forehead, down-slanting palpe-
bral fissures, hypertelorism and depressed nasal bridge), 
Dandy-Walker malformation, congenital heart defects, 
hypotonia, hearing loss, and others, with high phenotypic 
variability.23,24 The father of case 12 presented the same 
phenotype as his son. 
Case 15 was more compatible with chromosome 15q26-
qter deletion syndrome, characterized by pre and postnatal 
growth retardation, variable ID, mild non-specific facial dys-
morphisms and other congenital abnormalities.25 
Case 18’s manifestations seem to be caused mainly by 
9p duplication as patients with this syndrome present with 
peculiar facial dysmorphisms and digital abnormalities, as 
well as variable developmental delay/ID, cardiac and skel-
etal abnormalities.27
Case 20 could be misclassified as classic Down syn-
drome, since failure to thrive and other malformations (such 
as cardiac abnormalities) were missing. The 21q22 duplica-
tion was the dominant phenotype.28 
Case 21 was clinically diagnosed as Beckwith-
Wiedemann syndrome. This syndrome is mainly charac-
terized by macrosomia, macroglossia, hemihyperplasia, 
omphalocele, visceromegaly, embryonal tumours and neo-
natal hypoglicemia.29 
Cases 13, 16 and 17 presented with characteristics 
from both deletion and duplication and it was not possible to 
detect predominance of either (Table 1).
Focusing on genetic screening and counselling of the 
family, it is important to remember the examples of cases 4, 
5 and 6 and case 21. The first family is a good illustration 
of how balanced translocations may originate unbalanced 
gametes and affect different members of the same fami-
ly. Thus, it is essential to study those at risk. The second 
example shows an apparently innocuous family history 
but in whom the translocation is present and transmitted 
throughout three generations. 
In the aCGH era, it is tempting to perform only this tech-
nique in both children and parents to confirm a de novo occur-
rence; however, a normal aCGH result does not exclude 
a balanced translocation in parents, leaving the family at 
risk for chromosomal imbalances in future pregnancies of 
Figure 4 – Photos of patients showing dysmorphic features: cases number 21, 2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15, 17, 18, 19, 20. For 
all these cases, written informed consent was given to publish the photographs.
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healthy carriers. It is essential to study parents, by perform-
ing karyotype and FISH techniques when a deletion or dupli-
cation is found in a subtelomeric region, particularly when 
both a deletion and duplication are found in the proband, 
because the probability that a balanced rearrangement is 
present in one of the parents is very high in this situation.
CONCLUSION
This study shows that only after complete genetic char-
acterization is it possible to identify other relatives at risk 
and offer accurate genetic counselling and reproductive 
options, particularly invasive prenatal testing (either by cho-
rionic villous sampling or amniocentesis) or preimplantation 
genetic diagnosis.
The authors wish to emphasize that, although rare, 
these subtelomeric changes constitute a substantial cause 
of syndromic ID with important familial repercussions. It is 
essential to be aware of these cases and refer them to a 
Medical Genetics consultation, so that familial studies and 
management can be carried out accurately. 
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